JP2012529272A5 - - Google Patents

Download PDF

Info

Publication number
JP2012529272A5
JP2012529272A5 JP2012514307A JP2012514307A JP2012529272A5 JP 2012529272 A5 JP2012529272 A5 JP 2012529272A5 JP 2012514307 A JP2012514307 A JP 2012514307A JP 2012514307 A JP2012514307 A JP 2012514307A JP 2012529272 A5 JP2012529272 A5 JP 2012529272A5
Authority
JP
Japan
Prior art keywords
seq
angiopep
disease
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012514307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012529272A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2010/000889 external-priority patent/WO2010142035A1/en
Publication of JP2012529272A publication Critical patent/JP2012529272A/ja
Publication of JP2012529272A5 publication Critical patent/JP2012529272A5/ja
Pending legal-status Critical Current

Links

JP2012514307A 2009-06-11 2010-06-11 Gdnfおよびbdnfを中枢神経系へ送達するための融合タンパク質 Pending JP2012529272A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18624609P 2009-06-11 2009-06-11
US61/186,246 2009-06-11
PCT/CA2010/000889 WO2010142035A1 (en) 2009-06-11 2010-06-11 Fusion proteins for delivery of gdnf and bdnf to the central nervous system

Publications (2)

Publication Number Publication Date
JP2012529272A JP2012529272A (ja) 2012-11-22
JP2012529272A5 true JP2012529272A5 (enExample) 2013-07-25

Family

ID=43308346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012514307A Pending JP2012529272A (ja) 2009-06-11 2010-06-11 Gdnfおよびbdnfを中枢神経系へ送達するための融合タンパク質

Country Status (9)

Country Link
US (1) US20120196803A1 (enExample)
EP (1) EP2440581A4 (enExample)
JP (1) JP2012529272A (enExample)
CN (2) CN103819564A (enExample)
AU (1) AU2010258052A1 (enExample)
BR (1) BRPI1012971A2 (enExample)
CA (1) CA2764777A1 (enExample)
MX (1) MX2011013258A (enExample)
WO (1) WO2010142035A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4903036B2 (ja) 2003-01-06 2012-03-21 アンジオケム・インコーポレーテッド 血液脳関門を通過する担体としてのアプロチニンおよび類似体
WO2007009229A1 (en) 2005-07-15 2007-01-25 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
EP2074142A4 (en) 2006-10-19 2010-10-27 Angiochem Inc COMPOUNDS FOR STIMULATING THE FUNCTION OF P-GLYCOPROTEIN AND APPLICATIONS THEREOF
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
US9914754B2 (en) 2008-12-05 2018-03-13 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
AU2009327267A1 (en) 2008-12-17 2011-07-14 Angiochem, Inc. Membrane type-1 matrix metalloprotein inhibitors and uses thereof
ES2729261T3 (es) 2009-04-20 2019-10-31 Angiochem Inc Tratamiento del cáncer de ovario utilizando un agente anticancerígeno conjugado con un análogo de Angiopep-2
WO2011000095A1 (en) 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
WO2011153642A1 (en) * 2010-06-10 2011-12-15 Angiochem Inc. Leptin and leptin analog conjugates and fusion proteins and uses thereof
MX2013000250A (es) * 2010-07-02 2013-10-28 Angiochem Inc Polipeptidos cortos y que contienen d-aminoacido para conjugados terapeuticos y usos de los mismos.
JP2015526434A (ja) 2012-08-14 2015-09-10 アンジオケム インコーポレーテッド ペプチド−デンドリマーコンジュゲート及びその使用
JP6234331B2 (ja) * 2014-06-13 2017-11-22 森永乳業株式会社 統合失調症治療剤
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
JP7000349B2 (ja) 2016-05-13 2022-02-04 インスティテュート デ メディシナ モレキュラー ジョアオ ロボ アントゥネス Ilc3細胞に関連する疾患を処置する方法
AU2017357931B2 (en) 2016-11-10 2024-12-05 Keros Therapeutics, Inc. GDNF fusion polypeptides and methods of use thereof
CN107141354A (zh) * 2017-05-05 2017-09-08 李斯文 一种融合蛋白及光敏剂复合物及其制备方法和应用
WO2021015584A1 (ko) * 2019-07-24 2021-01-28 주식회사 에스엘바이젠 불사화된 줄기세포주의 제조 방법 및 이의 용도
JP2024522938A (ja) 2021-06-03 2024-06-21 フンダサン デー.アンナ ジ ソーメル チャンパリマウド エー ドクトル カルロス モンテス チャンパリマウド 脳-脂肪回路を介してilc2および肥満度を制御する神経-間葉単位
CN116270429B (zh) * 2023-02-17 2025-06-10 山东省药学科学院 一种鼻黏膜给药的抗抑郁制剂及其制备方法和应用
CN120077136A (zh) * 2023-09-28 2025-05-30 广州必贝特医药股份有限公司 抑制淀粉样前体蛋白(APP)基因表达的siRNA、药物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0520032A2 (pt) * 2005-02-18 2009-04-14 Angiochem Inc moléculas para transportar um composto através da barreira hematoencefálica
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
US8142781B2 (en) * 2005-10-07 2012-03-27 Armagen Technologies, Inc. Fusion proteins for blood-brain barrier delivery
AU2008255556B2 (en) * 2007-05-29 2014-08-07 Angiochem, Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US8802631B2 (en) * 2007-09-17 2014-08-12 Ludwig Institute For Cancer Research Ltd. Peptides and methods for the treatment of gliomas and other cancers
WO2009070597A2 (en) * 2007-11-26 2009-06-04 Armagen Technologies, Inc. Fusion proteins for delivery of gdnf to the cns

Similar Documents

Publication Publication Date Title
JP2012529272A5 (enExample)
JP2010534486A5 (enExample)
ES2393373T3 (es) Método para la producción de factor-I de crecimiento similar a la insulina
CN103998458B (zh) 具有中央疏水域的细胞穿透肽
TW200833840A (en) Toxin peptide therapeutic agents
JP2023181445A5 (enExample)
RU2016101711A (ru) Высокостабильный т-клеточный рецептор и способ его получения и применения
JP2005507637A5 (enExample)
JP2014525901A5 (enExample)
JP2019535267A5 (enExample)
JP2008508859A5 (enExample)
NO330538B1 (no) Anvendelse av hydrofob ladningsinduksjonskromatografi for fremstilling av renset IL-18-bindende protein samt fremgangsmate for fremstilling av renset IL -18-bindende protein
JP2012525844A5 (enExample)
JP2012176978A5 (enExample)
JP2014524908A5 (enExample)
JP2013526864A5 (enExample)
JP2010524958A5 (enExample)
JP2014513941A5 (enExample)
JP2007535910A5 (enExample)
JP2024012470A5 (enExample)
JP2009507503A5 (enExample)
RU2007146455A (ru) Варианты эритропоэтина
JP2008539745A5 (enExample)
JP2010509345A5 (enExample)
WO2008057609A4 (en) Methods of treating neuronal disorders using mntf peptides and analogs thereof